The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients.
A dual kinase inhibitor is entering a clinical trial for advanced pancreatic cancer in combination with gemcitabine.
A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy.
An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe.
Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial.
Clearing up chemo options for frail and elderly patients with advanced oesophageal and stomach cancers
Older patients with advanced oesophageal and stomach cancers might benefit from low dose treatment, according to our unpublished clinical trial results.
Less chemotherapy is as effective at controlling some advanced cancers for elderly patients, according to results of a Cancer Research UK funded trial.
Scientists could help match cancer patients with no other treatment options to clinical trials with experimental medicines
Combining a targeted cancer drug with an immunotherapy extends the lives of advanced kidney cancer patients, according to two clinical trials.